FET Clinical Trials in New York, New York
9 recruitingNew York, New York
Showing 1–9 of 9 trials
Recruiting
Phase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC120 enrolled61 locationsNCT05912517
Recruiting
Phase 1
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines140 enrolled20 locationsNCT06427941
Recruiting
Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
AVB - Atrioventricular BlockFetal AVB
NYU Langone Health1,300 enrolled24 locationsNCT04474223
Recruiting
Community Safety and Violence
Community-Centered Safety
NYU Langone Health15 enrolled1 locationNCT07494019
Recruiting
Phase 4
The Stimulation To Induce Mothers Study
Labor PainOxytocinPhysiologic Effects of Drugs+1 more
Yale University988 enrolled3 locationsNCT05079841
Recruiting
Phase 3
CAR-T Long Term Follow Up (LTFU) Study
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals1,400 enrolled118 locationsNCT02445222
Recruiting
School Violence Exposure as an Adverse Childhood Experience
Adverse Childhood ExperiencesMental Health OutcomesPerceived School Safety+1 more
Teachers College, Columbia University2,500 enrolled1 locationNCT06153316
Recruiting
An Ophthalmic Safety Study in Patients With Breast Cancer
Ophthalmic Safety in Patients With Breast Cancer
AstraZeneca160 enrolled75 locationsNCT06767462
Recruiting
USCOM in Newly Diagnosed FGR Cases
Fetal Growth RestrictionUSCOM
Icahn School of Medicine at Mount Sinai100 enrolled1 locationNCT06343051